Canada markets closed

Reviva Pharmaceuticals Holdings, Inc. (RVPH)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.2000+0.0200 (+0.63%)
At close: 04:00PM EDT
3.2000 0.00 (0.00%)
After hours: 04:00PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 88.78M
Enterprise Value 84.03M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)15.52
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.13

Trading Information

Stock Price History

Beta (5Y Monthly) -0.02
52-Week Change 3-61.96%
S&P500 52-Week Change 322.38%
52 Week High 39.2200
52 Week Low 32.6700
50-Day Moving Average 33.4314
200-Day Moving Average 34.2053

Share Statistics

Avg Vol (3 month) 3260.1k
Avg Vol (10 day) 3102.7k
Shares Outstanding 527.92M
Implied Shares Outstanding 627.92M
Float 821.13M
% Held by Insiders 117.71%
% Held by Institutions 117.93%
Shares Short (Apr 15, 2024) 41.23M
Short Ratio (Apr 15, 2024) 43.37
Short % of Float (Apr 15, 2024) 46.63%
Short % of Shares Outstanding (Apr 15, 2024) 44.42%
Shares Short (prior month Mar 15, 2024) 4650.65k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-115.85%
Return on Equity (ttm)-556.38%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-39.26M
Diluted EPS (ttm)-1.6500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)23.37M
Total Cash Per Share (mrq)0.84
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.38
Book Value Per Share (mrq)0.20

Cash Flow Statement

Operating Cash Flow (ttm)-28.32M
Levered Free Cash Flow (ttm)-13.99M